[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6079 followers
Created: 2025-07-23 10:47:58 UTC

Thyrocare Q1FY26 Results: XX% Revenue Growth & XX% PAT Surge 🚀 | MCap XXXXXXXX Cr

- Consolidated revenue grew by XX% YoY to ₹193.03 Cr.
- Pathology business grew by XX% YoY; Radiology up X% YoY.
- Franchise revenue (Pathology) rose XX% YoY; partnership revenue surged XX% YoY.
- Total test volume hit 46.9M, a XX% YoY increase.
- Gross Margin at 71%; EBITDA margin at 30%.
- EBITDA grew XX% YoY to ₹57.46 Cr.
- PAT jumped XX% YoY to ₹38.06 Cr.
- New labs opened in Bhagalpur, Kashmir, and Roorkee.
- Quarterly active franchises: 9,500+.
- Quality accreditations: ISO 9001:2015, NABL, and CAP.

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

![](https://pbs.twimg.com/media/GwiWDNpbcAA4Q16.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947971948581146859/c:line.svg)

**Related Topics**
[mcap](/topic/mcap)
[surge](/topic/surge)
[quarterly earnings](/topic/quarterly-earnings)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1947971948581146859)